相关实验视频
Updated: Mar 9, 2026

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.7K
血管肉瘤:诊断,预后和治疗策略中的生物标志物的系统审查
Sofie Vercammen1,2, Huyen Thuc Tran Luong3,4, Hilde De Cock1,5
1Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Belgium.
Veterinary and comparative oncology
|March 7, 2026
概括
本综述确定了犬血肉瘤 (HSA) 的关键诊断,预后和治疗生物标志物,这是一种具有挑战性的血管瘤. 这些发现支持通过比较瘤学开发犬类HSA的新治疗方法和诊断工具.
科学领域:
- 兽医瘤学 兽医瘤学
- 比较病理学比较病理学
- 生物标志物发现发现
背景情况:
- 狗血肉瘤 (HSA) 是一种具有不良预后的侵袭性血管瘤.
- 目前用于犬类HSA的治疗方法的疗效有限,需要新的治疗策略.
- 了解生物标志物对于改善诊断和治疗结果至关重要.
研究的目的:
- 系统地审查和综合有关犬血肉瘤的诊断,预后和治疗生物标志物的证据.
- 在人类血管肉瘤的现有研究基础上建立比较瘤学的洞察力.
- 确定知识差距,并指导未来对犬类HSA生物标志物开发的研究.
主要方法:
- 一个符合PRISMA的PubMed和Embase (1996-2024) 的系统文献搜索.
- 包括51项符合条件的研究,重点关注犬血肉瘤生物标志物.
- 使用纽卡斯尔-太华尺度进行方法性质量评估.
主要成果:
- 确定了对犬类HSA有希望的蛋白质,分子和血液学生物标志物候选者.
- 评估了这些潜在生物标志物的临床相关性.
- 突出了当前文学和有关犬类HSA生物标志物的知识的重大差距.
结论:
- 该审查为人类和犬类血管肉瘤之间的比较瘤研究提供了基础.
- 已识别的生物标志物显示出开发犬类HSA新型诊断工具的潜力.
- 这些发现支持开发有针对性的疗法,以改善犬血肉瘤管理.
更多相关视频
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
6.1K
08:26A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay
Published on: April 12, 2018
8.6K
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cancer Survival Analysis
807
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
807